Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation

Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation
复制标题

DOI:
10.1074/jbc.m115.683045
复制
发表时间:
2015-11-13
影响因子:
4.8
通讯作者:
Regnier, Michael
Regnier, Michael
中科院分区:
生物学2区
文献类型:
--
作者:
Cheng, Yuanhua;Rao, Vijay;Regnier, Michael

文献摘要

被引文献

相似文献

两个肥厚性心肌病相关的心肌肌钙蛋白I (cTnI)突变R146G和R21C位于cTnI、抑制肽和心脏特异性N端的不同区域。我们最近报道,当Ser-23/Ser-24被磷酸化时,这些区域可能相互作用,削弱cTnI与心脏TnC的相互作用。对于这些突变如何影响心脏TnC对cTnI (KC-I)的亲和力或β -肾上腺素能刺激时的收缩动力学,我们知之甚少。在这里,我们测试了cTnI(R146G)或cTnI(R21C)如何影响收缩激活和松弛以及它们对蛋白激酶A (PKA)的反应。这两种突变都显著增加了Ca2+与cTn (K-Ca)和KC-I的结合亲和力。PKA磷酸化导致所有复合物中K-Ca的相似减少,但KC-I仅与cTnI(WT)一起减少。将cTnI(WT)、cTnI(R146G)和cTnI(R21C)配合成心肌肌钙蛋白并交换到大鼠心室肌原纤维中,测量PKA磷酸化+/- PKA磷酸化后收缩/舒张动力学。cTnI(R146G)和cTnI(R21C)交换的肌原纤维保持最大张力(T-max),张力(pCa(50))增加。PKA磷酸化降低了cTnI(WT)交换肌原纤维的pCa(50),但对两种突变均无影响。PKA磷酸化加速了cTnI(WT)肌原纤维的早期慢相松弛,特别是在心脏体内运行的Ca2+水平下。重要的是,这种作用在cTnI(R146G)和cTnI(R21C)交换的肌原纤维中被减弱。分子动力学模拟表明,这两种突变都抑制了N端和cTnI抑制肽之间亚基内接触的形成,这种接触通常在PKA磷酸化后的WT-cTn中可见。总之,我们的研究结果表明,cTnI(R146G)和cTnI(R21C)通过禁止心脏特异性n端与cTnI抑制肽的相互作用,减弱了PKA对激活和松弛动力学的调节。
Two hypertrophic cardiomyopathy-associated cardiac troponin I (cTnI) mutations, R146G and R21C, are located in different regions of cTnI, the inhibitory peptide and the cardiac-specific N terminus. We recently reported that these regions may interact when Ser-23/Ser-24 are phosphorylated, weakening the interaction of cTnI with cardiac TnC. Little is known about how these mutations influence the affinity of cardiac TnC for cTnI (KC-I) or contractile kinetics during beta-adrenergic stimulation. Here, we tested how cTnI(R146G) or cTnI(R21C) influences contractile activation and relaxation and their response to protein kinase A (PKA). Both mutations significantly increased Ca2+ binding affinity to cTn (K-Ca) and KC-I. PKA phosphorylation resulted in a similar reduction of K-Ca for all complexes, but KC-I was reduced only with cTnI(WT). cTnI(WT), cTnI(R146G), and cTnI(R21C) were complexed into cardiac troponin and exchanged into rat ventricular myofibrils, and contraction/relaxation kinetics were measured +/- PKA phosphorylation. Maximal tension (T-max) was maintained for cTnI(R146G)- and cTnI(R21C)-exchanged myofibrils, and Ca2+ sensitivity of tension (pCa(50)) was increased. PKA phosphorylation decreased pCa(50) for cTnI(WT)-exchanged myofibrils but not for either mutation. PKA phosphorylation accelerated the early slow phase relaxation for cTnI(WT) myofibrils, especially at Ca2+ levels that the heart operates in vivo. Importantly, this effect was blunted for cTnI(R146G)- and cTnI(R21C)-exchanged myofibrils. Molecular dynamics simulations suggest both mutations inhibit formation of intra-subunit contacts between the N terminus and the inhibitory peptide of cTnI that is normally seen with WT-cTn upon PKA phosphorylation. Together, our results suggest that cTnI(R146G) and cTnI(R21C) blunt PKA modulation of activation and relaxation kinetics by prohibiting cardiac-specific N-terminal interaction with the cTnI inhibitory peptide.